Financial Gravity Asset Management, Inc. Cumberland Pharmaceuticals Inc Transaction History

Financial Gravity Asset Management, Inc.

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2020 May 12, 2020	SELL	$3.45 - $5.33 $6,900 - $10,660	-2,000 Closed	0 $0
Q4 2019 Feb 28, 2020	SELL	$4.68 - $5.79 $18,720 - $23,160	-4,000 Reduced 66.67%	2,000 $10,000
Q3 2019 Oct 15, 2019	BUY	$4.73 - $6.4 $28,380 - $38,400	6,000 New	6,000 $36,000

1.97M

44.2K

Ticker CPIX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 14,661,900
Market Cap $33.3M
Description
Cumberland Pharmaceuticals Inc., a specialty pharmaceutical company, focuses on the acquisition, development, and commercialization of prescription products for hospital acute care, gastroenterology, rheumatology, and oncology in the United States and internationally. The company offers Acetadote, an injection for the treatment of acetaminophen ...

Get notified when there are updates to the investment portfolio of Financial Gravity Asset Management, Inc., based on Form 13F filings with the SEC.

Stay updated on Financial Gravity Asset Management, Inc. with notifications on news.